Navigation Links
From eResearchTechnology to ERT
Date:2/26/2009

The Philadelphia-based company unveils its dynamic new identity and commits to 'Getting It Done, Right'

PHILADELPHIA, Feb. 26 /PRNewswire/ -- ERT (Nasdaq: ERES), the leading provider of best-in-class technology and services for the successful execution of clinical trials, today announced that, following extensive external and internal assessment, it is launching its new branding. Formerly eResearchTechnology, Inc., the company has adopted an entirely new image and character for the company following staff feedback and customer affirmation of its core values. The unrivalled business found that both customers and employees expect and receive a commitment from ERT that it will get the job done, and right. ERT is a dynamic and proactive organization that is committed to redefining and setting new standards of how clinical trials are successfully conducted.

This new brand strategy brings an enhanced visual identity to market as well as sharpened product positioning, a new web site, messaging and corporate collateral. As part of its new branding commitment ERT has introduced a new platform of products and services in the clinical trials arena to its customers worldwide. This consists of four sub-brands for ERT's industry-leading products and services: Cardiac Safety Solutions; EDC Solutions; ePRO Solutions and ERT Clinical Research Consulting Group. Cardiac Safety, EDC and ePRO Solutions are founded upon the company's innovative technology platform -- EXPERT(TM). EXPERT(TM) is a robust, secure and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management and information exchange. All of ERT's solutions are supported by cross-functional teams operating within its SOP-driven, Project Assurance methodology that delivers exceptional performance metrics and customer satisfaction.

Originally founded in 1972 as Cardio Data Systems, the company moved its headquarters to Philadelphia in 1993 and following a series of acquisitions formed the company eResearchTechnology Inc. in 2000. "eResearchTechnology was known as a company that offered unparalleled service and comprehensive and reliable solutions which helped companies bring safe products to market," commented Michael McKelvey, President and CEO of ERT. "Our new brand identity reflects ERT's dynamism and passion while continuing to instill the confidence and trust that the industry has in our products and services. We see the change as a move forward in establishing the company as the most experienced and reliable partner in products and services for clinical trials. ERT gets the job done right."

For further information on ERT and its technology and services please email info@ert.com, call +1 215 972 0420 or visit www.ert.com.

About ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ERT.com) is a provider of technology and services to the biopharmaceutical and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE eResearchTechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):